Glucovance is a prescription medication that combines metformin hydrochloride (500 mg) and glibenclamide (5 mg) in each film-coated tablet. Manufactured by Merck, this combination therapy helps control blood sugar levels in patients with type 2 diabetes. The package contains 30 film-coated tablets. The medication works through dual mechanisms - metformin reduces glucose production in the liver and improves insulin sensitivity, while glibenclamide stimulates insulin release from the pancreas. The film coating helps protect the active ingredients and makes the tablets easier to swallow. The product comes in Merck's distinctive white and red packaging with clear labeling of active ingredients and dosage strength. As a prescription medication, it should only be taken under medical supervision according to prescribed dosage.